Stocks / NASDAQ / Akero Therapeutics, Inc.

Akero Therapeutics, Inc.

Our Opinion

Akero Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“The Milestone Event is defined as the earlier of (a) a successful completion of a 90 or 120 day chronic toxicity animal studies, and (b) identification of sufficient therapeutic index for a Phase 2 clinical trial.” (Page F-19) Read the full document

Company Description

Company Website: